Omega Fund Management, LLC
CIK 1637359 · Holdings on Mar 31, 2024 · First reported May 14, 2024
Top ten holdings
Q1 2024- NUVB33.05%
- LXEO23.83%
- REPL15.82%
- 29286M10511.77%
- SANA5.44%
- MORF3.63%
- 45175G1082.06%
- VTL1.52%
- ENGNW1.21%
- SYRS0.87%
Share classes counted separately99.20%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- NUVBWeight increased · +14.61 pp18.44% → 33.05%Shares -1.00M (-6.63%)
- REPLWeight decreased · -4.68 pp20.50% → 15.82%Shares 0 (0.00%)
- MORFWeight decreased · -3.62 pp7.25% → 3.63%Shares -150.00K (-48.41%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 11
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NUVBNUVATION BIO INCCommon Stock Class A View history and evidence | $51.22M | 33.05% | 14.07M shares | 18.44% → 33.05%+14.61 pp -1.00M (-6.63%) | Reduced | ↗▾ |
| 02 | LXEOLEXEO THERAPEUTICS INCCommon Stock View history and evidence | $36.94M | 23.83% | 2.36M shares | 23.46% → 23.83%+0.37 pp +198.28K (+9.19%) | Added | ↗▾ |
| 03 | REPLREPLIMUNE GROUP INCCommon Stock View history and evidence | $24.52M | 15.82% | 3.00M shares | 20.50% → 15.82%-4.68 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | 29286M105enGene Holdings Inc.Common Stock View history and evidence | $18.24M | 11.77% | 1.08M shares | 8.46% → 11.77%+3.31 pp -54.82K (-4.85%) | Reduced | ↗▾ |
| 05 | SANASANA BIOTECHNOLOGY INCCommon Stock View history and evidence | $8.44M | 5.44% | 843.75K shares | 2.79% → 5.44%+2.65 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | MORFMORPHIC HOLDING INCCommon Stock View history and evidence | $5.63M | 3.63% | 159.85K shares | 7.25% → 3.63%-3.62 pp -150.00K (-48.41%) | Reduced | ↗▾ |
| 07 | 45175G108Ikena OncologyCommon Stock View history and evidence | $3.19M | 2.06% | 2.25M shares | 3.59% → 2.06%-1.53 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | VTLIMMUNIC INCCommon Stock View history and evidence | $2.36M | 1.52% | 1.79M shares | 2.17% → 1.52%-0.65 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | ENGNWENGENE HOLDINGS INC-28Warrant View history and evidence | $1.88M | 1.21% | 360.90K shares | 0.33% → 1.21%+0.88 pp -114.17K (-24.03%) | Reduced | ↗▾ |
| 10 | SYRSSYROS PHARMACEUTICALS INCCommon Stock View history and evidence | $1.34M | 0.87% | 251.27K shares | 1.59% → 0.87%-0.72 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| 85209E109 Spruce Biosciences | Non-derivative | -2,161,022 | -$6.33M | SEC filing ↗ | SEC filing ↗ |
| 88369M101 Theseus Pharmaceuticals | Non-derivative | -711,479 | -$2.88M | SEC filing ↗ | SEC filing ↗ |
| 81726A100 Senti Biosciences, Inc. | Non-derivative | -195,792 | -$129.22K | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1637359 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-05-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 155010742
}Take these holdings further.
This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 11 of 11 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1637359","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1637359","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.